You have access
A Single Low Dose of Eribulin Regressed a Highly Aggressive Triple-negative Breast Cancer in a Patient-derived Orthotopic Xenograft Model
HYE IN LIM, JUN YAMAMOTO, SACHIKO INUBUSHI, HIROTO NISHINO, YOSHIHIKO TASHIRO, NORIHIKO SUGISAWA, QUINHONG HAN, YU SUN, HEE JUN CHOI, SEOK JIN NAM, MOON BO KIM, JI SUN LEE, CHIHIRO HOZUMI, MICHAEL BOUVET, SHREE RAM SINGH and ROBERT M. HOFFMAN
Anticancer Research May 2020, 40 (5) 2481-2485; DOI: https://doi.org/10.21873/anticanres.14218